Search Results 461-470 of 16080 for SC

  1. A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies (MorningSun) - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness, safety, and pharmacokinetics of mosunetuzumab subcutaneous (SC) formulation in participants with ...

  2. Publications - Patrick B. Johnston, M.D., Ph.D. - Mayo Clinic

    ... SC. Patterns of progression after immune checkpoint inhibitors for Hodgkin lymphoma: implications for radiation therapy. Blood Adv. 2024 Mar 12; 8 (5):1250 ...

  3. Pulmonary Hypertension Association Registry - Mayo Clinic

    Gerald; Mathai SC. Stephen C; Hassoun PM. Paul M; . . Pulmonary circulation. 2023. Jul; 13(3):e12281. The prevalence of acute vasodilator response (AVR) to ...

  4. Spinal cord tumor - Doctors and departments - Mayo Clinic

    Spinal cord tumors can cause serious problems such as pain and paralysis. Find out how more about management and treatment.

  5. Publications - Meera Sridharan, M.D., Ph.D. - Mayo Clinic

    ... SC, Sridharan M. Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation. Blood Adv. 2023 Feb ...

  6. Gastroenterology and Hepatology - Clinical trials

    The purpose of this study is to assess the pharmacodynamics (PD) of HM15211 after administration of multiple subcutaneous (SC) doses compared to placebo on ...

  7. Epigenomics and Spatial Biology Core - Mayo Clinic Research

    Single cell (sc) ATAC-seq. Single-cell ATAC-seq combined with gene expression (scATAC+GEX). Single-cell GEX Flex, a single-cell transcriptome assay for ...

  8. Gene Therapy Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine the safety of sc-rAAV2.5IL-1Ra, a gene therapy carried by a virus and delivered by injection into the knee joint of ...

  9. A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma - Mayo Clinic

    The primary objective of this study is to determine whether treatment with daratumumab administered subcutaneously (SC) prolongs progression-free survival ...

  10. Gastroenterology and Hepatology - Clinical trials

    The purpose of this study is to assess the pharmacodynamics (PD) of HM15211 after administration of multiple subcutaneous (SC) doses compared to placebo on ...